Organizing for cures

FDA’s oversight of medical products is overdue for major reorganization, one that aligns the agency’s structure with the goals that matter most to patients and society. It should be focused on diseases, not technologies, with teams dedicated to creating conditions that can pave the way for products that produce exponential improvements in health.

The organization of FDA, or the dedicated medical products regulator Back to School is calling for, should reflect the ways medicine is practiced and, importantly, the ways patients experience disease. ...